Critical Review of Preclinical Approaches to Investigate Cytochrome P450–Mediated Therapeutic Protein Drug-Drug Interactions and Recommendations for Best Practices: A White Paper-Reference-Cited by-同舟云学术

Critical Review of Preclinical Approaches to Investigate Cytochrome P450–Mediated Therapeutic Protein Drug-Drug Interactions and Recommendations for Best Practices: A White Paper

Published:2013-06-21 Issue:9 Volume:41 Page:1598-1609
ISSN:0090-9556
Container-title:Drug Metabolism and Disposition
language:en
Short-container-title:Drug Metab Dispos

Author:

Evers Raymond,Dallas Shannon,Dickmann Leslie J.,Fahmi Odette A.,Kenny Jane R.,Kraynov Eugenia,Nguyen Theresa,Patel Aarti H.,Slatter J. Greg,Zhang Lei

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmaceutical Science,Pharmacology

Reference65 articles.

1. Cytokines down-regulate expression of major cytochrome P-450 enzymes in adult human hepatocytes in primary culture;Abdel-Razzak;Mol Pharmacol,1993

2. Gene-Specific Effects of Inflammatory Cytokines on Cytochrome P450 2C, 2B6 and 3A4 mRNA Levels in Human Hepatocytes

3. REGULATION OF DRUG-METABOLIZING ENZYMES AND TRANSPORTERS IN INFLAMMATION

4. Effect of interleukin-6 neutralization on CYP3A11 and metallothionein-1/2 expressions in arthritic mouse liver

5. A stable long-term hepatocyte culture system for studies of physiologic processes: cytokine stimulation of the acute phase response in rat and human hepatocytes

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serum Profiles of Solifenacin and Interleukin-6 and Their Relationship With Psychiatric Symptoms in a Patient With Overactive Bladder Syndrome and Systemic Inflammation;Therapeutic Drug Monitoring;2024-07-12

2. Evaluating drug interaction potential from cytokine release syndrome using a physiologically based pharmacokinetic model: A case study of teclistamab;CPT: Pharmacometrics & Systems Pharmacology;2024-06-03

3. Generation and characterization of cytochrome P450 3A74 CRISPR/Cas9 knockout bovine foetal hepatocyte cell line (BFH12);Biochemical Pharmacology;2024-06

4. Assessment of CYP3A‐mediated drug interaction via cytokine (IL‐6) elevation for mosunetuzumab using physiologically‐based pharmacokinetic modeling;CPT: Pharmacometrics & Systems Pharmacology;2023-12-04

5. Regulatory Considerations in Metabolism‐ and Transport‐Based Drug Interactions;Oral Bioavailability and Drug Delivery;2023-10-10